XSHG600381
Market cap262mUSD
Dec 25, Last price
3.29CNY
1D
-1.79%
1Q
14.24%
Jan 2017
-78.66%
Name
Qinghai Spring Medicinl Rsrcs Tech CoLTD
Chart & Performance
Profile
Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business. The company was founded in 2003 and is based in Xining, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 213,877 33.52% | 160,178 25.37% | 127,764 2.81% | |||||||
Cost of revenue | 288,047 | 235,189 | 179,811 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (74,171) | (75,011) | (52,047) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | 5,930 | |||||||||
Tax Rate | ||||||||||
NOPAT | (80,101) | (75,011) | (52,047) | |||||||
Net income | (267,865) | |||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,950 | 549 | ||||||||
Long-term debt | 19,668 | 5,891 | 1,155 | |||||||
Deferred revenue | 1,628 | 2,358 | ||||||||
Other long-term liabilities | 1,016 | 1 | 1 | |||||||
Net debt | (242,263) | (389,819) | (434,198) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 23,917 | |||||||||
CAPEX | (13,531) | (121,794) | ||||||||
Cash from investing activities | 36,159 | 48,660 | ||||||||
Cash from financing activities | (8,531) | (895) | ||||||||
FCF | 29,469 | 84,565 | 89,996 | |||||||
Balance | ||||||||||
Cash | 172,930 | 169,347 | 199,586 | |||||||
Long term investments | 89,001 | 228,313 | 236,316 | |||||||
Excess cash | 251,237 | 389,651 | 429,514 | |||||||
Stockholders' equity | 923,359 | 1,295,557 | 1,583,106 | |||||||
Invested Capital | 1,026,931 | 1,149,740 | 1,394,266 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 582,316 | 587,061 | 587,061 | |||||||
Price | 7.73 -37.21% | 12.31 46.03% | 8.43 -2.09% | |||||||
Market cap | 4,501,301 -37.71% | 7,226,718 46.03% | 4,948,922 -2.09% | |||||||
EV | 4,261,290 | 6,836,899 | 4,514,724 | |||||||
EBITDA | (44,376) | (33,500) | (10,032) | |||||||
EV/EBITDA | ||||||||||
Interest | 962 | 92 | 52 | |||||||
Interest/NOPBT |